The Association Between Hypotonia and Brain Tumors in Children With Neurofibromatosis Type 1

Wessel, Lauren E.; Albers, Anne C.; Gutmann, David H.; Dunn, Courtney M.
December 2013
Journal of Child Neurology;Dec2013, Vol. 28 Issue 12, p1664
Academic Journal
Children with the neurofibromatosis type 1 (NF1) inherited tumor predisposition syndrome are at risk for the development of brain tumors. In addition, children with neurofibromatosis type 1 often exhibit low tone (hypotonia). In this study, the authors explored the hypothesis that hypotonia could be a clinical indicator of glioma in children with neurofibromatosis type 1. A total of 56 children between 1 and 7 years of age with a confirmed diagnosis of neurofibromatosis type 1 were evaluated. Brain magnetic resonance imaging (MRI) was available for 19 of these children. Chi-square analysis demonstrated a statistically significant correlation between hypotonia and glioma in children with neurofibromatosis type 1 (90% sensitivity and 78% specificity). These results suggest that hypotonia might be a clinically useful indicator of brain tumor in this at-risk population.


Related Articles

  • Should a child with neurofibromatosis type 1 be screened for central nervous system tumours with neuroimaging? Bodey, Caroline; Seal, Arnab // Archives of Disease in Childhood;Jun2014, Vol. 99 Issue 6, p595 

    The article presents a case study of a four-year-old boy who was diagnosed with neurofibromatosis type 1 (NF1) disease and discusses the need for the screening of optic pathway gliomas (OPG) with magnetic resonance imaging (MRI). Topics discussed include complications associated with brain...

  • Height Assessments in Children With Neurofibromatosis Type 1. Soucy, Elizabeth A.; van Oppen, Dorothy; Nejedly, Nicole L.; Gao, Feng; Gutmann, David H.; Hollander, Abby S. // Journal of Child Neurology;Mar2013, Vol. 28 Issue 3, p303 

    Previous studies have suggested that children with neurofibromatosis type 1 (NF1) are shorter than their unaffected counterparts. Unfortunately, these reports did not consider other contributing factors that might also influence short stature. The purpose of the current study was to characterize...

  • Oncologic manifestations in children with neurofibromatosis type 1 in Turkey. Faruk İncecik; Şakir Altunbaşak; M. Özlem Hergüner; İbrahim Bayram; Serhan Küpeli; Hüseyin Demirbilek // Turkish Journal of Pediatrics;May/Jun2013, Vol. 55 Issue 3, p266 

    Children with neurofibromatosis type 1 (NF1) are predisposed to malignancies such as brain tumors, leukemia, and pheochromocytomas. The aim of this study was to evaluate malignancy in patients with NF1. We studied 120 patients with NF1 in this study. Demographic data from these patients were...

  • Differential Diagnosis in Pediatric Dermatology.  // European Journal of Pediatric Dermatolgy;Jul-Sep2014, Vol. 24 Issue 3, p132 

    The article offers a guide to differentiating neurofibromatosis 1 from idiopathic eruptive macular pigmentation in children.

  • Neurofibromatosis type 1 (NF1) with an unusually severe phenotype due to digeny for NF1 and ryanodine receptor 1 associated myopathy. Martin, Florence; Kana, Veronika; Mori, Andrea; Fischer, Dirk; Parkin, Nicolas; Boltshauser, Eugen; Rushing, Elisabeth; Klein, Andrea // European Journal of Pediatrics;Dec2014, Vol. 173 Issue 12, p1691 

    We describe a 5-year-old girl with marked hypotonia, poor feeding and reduced facial expression since birth. Congenital myopathy was suspected; muscle biopsy showed unspecific type 1 fibre predominance. The possibility of a ryanodine receptor 1 gene ( RYR1)-associated myopathy was considered,...

  • Suprasellar pilocytic astrocytoma: one national centre's experience. Mandiwanza, Tafadzwa; Kaliaperumal, Chandrasekaran; Khalil, Ayman; Sattar, Muhammad; Crimmins, Darach; Caird, John // Child's Nervous System;Jul2014, Vol. 30 Issue 7, p1243 

    Introduction: Pilocytic astrocytomas in the supratentorial compartment make up 20 % of all brain tumours in children with only 5 % of these arising in the suprasellar region. Optic pathway gliomas or suprasellar gliomas are often seen in neurofibromatosis type 1 (NF1) patients. Given their...

  • A rare case of neurofibromatosis - type 1. Varghese, Prithvi; Muhammed Jasim Abdul Jalal // Asian Journal of Neurosurgery;Oct-Dec2015, Vol. 10 Issue 4, p344 

    Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant familial tumor syndrome. Glioblastoma is a malignant brain tumor but is a rare occurrence in patients with NF1. Here, we report a rare occurrence of glioblastoma in a 60-year-old man with NF1, who...

  • Longitudinal Analysis of Developmental Delays in Children With Neurofibromatosis Type 1. Wessel, Lauren E.; Gao, Feng; Gutmann, David H.; Dunn, Courtney M. // Journal of Child Neurology;Dec2013, Vol. 28 Issue 12, p1689 

    Children with neurofibromatosis type 1 exhibit a variety of developmental delays. However, there is little information about the progression of these deficits over the course of development. Using the Parents’ Evaluation of Developmental Status measurement tool, we assessed 124 infants...

  • Diencephalic syndrome as sign of tumor progression in a child with neurofibromatosis type 1 and optic pathway glioma: a case report. Cavicchiolo, Maria; Opocher, Enrico; Daverio, Marco; Bendini, Matteo; Viscardi, Elisabetta; Bisogno, Gianni; Perilongo, Giorgio; Da Dalt, Liviana // Child's Nervous System;Oct2013, Vol. 29 Issue 10, p1941 

    Illustrative case: We describe the case of a 3-year-old child, diagnosed with familial neurofibromatosis type 1 (NF1) and asymptomatic optic pathway tumor at the age of two, who developed diencephalic syndrome (DS) due to tumor progression 1 year after diagnosis. Magnetic resonance imaging...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics